XML 42 R22.htm IDEA: XBRL DOCUMENT v3.26.3
Income Taxes
12 Months Ended
Oct. 03, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
U.S. and foreign income taxes consist of the following:
2026
2025
2024
Current:
Federal
$
9,835 
$
30,351 
$
50,813 
Foreign
53,644 
48,018 
31,210 
State
8,115 
5,795 
8,588 
Total current
71,594 
84,164 
90,611 
Deferred:
Federal
(8,663)
(10,142)
(29,268)
Foreign
2,246 
4,197 
2,589 
State
(1,278)
(599)
(2,972)
Total deferred
(7,695)
(6,544)
(29,651)
Income taxes
$
63,899 
$
77,620 
$
60,960 
The reconciliation of the U.S. federal statutory tax rate to the effective income tax rate applying ASU 2023-09 prospectively is as follows:

2026
AmountRate
Earnings before income taxes:
Domestic$322,599 
Foreign161,221 
Total$483,820 
U.S. federal statutory rate$101,602 21.0 %
Increase (decrease) in income taxes resulting from:
State and local Income tax, net of federal income tax effect(1)
5,397 1.1 %
Foreign tax effect
Germany5,549 1.1 %
All other jurisdictions11,318 2.3 %
Effect of cross-border tax laws, net of foreign tax credits
Foreign-derived intangible income(1,208)(0.2)%
Global intangible low-taxed income(175)— %
Effect of changes in tax laws or rates enacted in the current period
Nontaxable or nondeductible items
Employee compensation(3,245)(0.7)%
Other1,449 0.3 %
Tax credits
Research and development ("R&D")(47,832)(9.9)%
Foreign tax credits(3,773)(0.8)%
Changes in valuation allowance(506)(0.1)%
Changes in unrecognized tax benefits5,823 1.2 %
Other
Legal entity simplification(7,774)(1.6)%
Other(2,726)(0.6)%
Effective income tax rate$63,899 13.2 %
(1)California, Texas, Connecticut, Pennsylvania and Illinois account for the majority of the effect of the state and local income tax category.
We identified, in the current year, additional expenditures qualifying for U.S. research and development tax credits through an enhanced review of our research activities and related costs. As a result, we recorded a tax benefit of approximately $40,125, offset by an approximate $5,762 reduction representing unrecognized tax benefits related to the additional qualifying expenditures. The benefit reflects improved identification and documentation of qualifying expenditures and does not represent a change in our underlying research and development activities. We also recognized an income tax benefit of approximately $7,774 related to legal entity simplification initiatives.
The reconciliation from the statutory federal income tax rate to our effective income tax rate, applying ASC 740 prior to the adoption of ASU 2023-09, follows:
2025
2024
Earnings before income taxes:
Domestic
$167,179 
$186,376 
Foreign
145,469 
83,370 
Total
$
312,648 
$
269,746 
U.S. federal statutory rate21.0 %21.0 %
Increase (decrease) in income taxes resulting from:
Impacts of the Tax Cut and Jobs Act ("TCJA")0.2 %(1.2)%
Tax on foreign earnings1.3 %0.8 %
R&D and foreign tax credits(3.8)%(4.3)%
Foreign tax rates3.8 %2.7 %
State taxes, net of federal benefit0.5 %0.8 %
Change in valuation allowance for deferred taxes0.5 %1.7 %
Divestiture impacts0.4 %0.5 %
Equity-based compensation and benefits— %0.2 %
Other
0.9 
%
0.4 
%
Effective income tax rate
24.8 
%
22.6 
%
During 2026, 2025 and 2024, we repatriated available unremitted earnings from various foreign subsidiaries that were previously taxed. We no longer indefinitely reinvest unremitted earnings for the majority of our subsidiaries and therefore we record a liability related to the remaining unremitted earnings generated by the foreign subsidiaries in the current year. We continue to be permanently invested in outside basis differences other than the unremitted earnings as we have no plans to liquidate or sell those foreign subsidiaries.
Cash paid for income taxes (net of refunds) consisted of the following:
2026
Federal$41,149 
State7,112 
Foreign
Canada5,580 
China5,944 
Germany10,828 
Japan5,388 
All Other Jurisdictions23,531 
Cash paid for income taxes (net of refunds)$99,532 
The tax effects of temporary differences that generated deferred tax assets and liabilities are as follows:
October 3,
2026
September 27,
2025
Deferred tax assets:
Research and development
$
95,380 
$
86,109 
Benefit accruals
35,950 
46,669 
Inventory reserves
31,935 
28,139 
Lease liability
25,550 
15,756 
Contract reserves not currently deductible
19,295 
18,713 
Tax benefit carryforwards
15,052 
13,180 
Other accrued expenses
1,660 
— 
Total gross deferred tax assets
224,822 
208,566 
Less valuation allowance(1)
(14,969)
(12,317)
Total net deferred tax assets
$
209,853 
$
196,249 
Deferred tax liabilities:
Differences in bases and depreciation of property, plant and equipment
$
204,397 
$
189,878 
Pension
16,587 
14,881 
Other
— 
1,631 
Total gross deferred tax liabilities
220,984 
206,390 
Net deferred tax liabilities
$
(11,131)
$
(10,141)
(1) State tax credit carryforwards have expiration dates from 2027 to indefinite.

As a result of the TCJA, taxpayers were required to capitalize and amortize research and development costs pursuant to IRC Section 174. A deferred tax asset was established beginning in 2023 and is reflected in the table above. Following the enactment of the One Big Beautiful Bill Act of 2025, qualifying domestic research and experimental expenditures are no longer required to be capitalized and amortized and may generally be deducted as incurred. Accordingly, we expect the deferred tax asset associated with previously capitalized Section 174 expenditures to reverse in future periods.
The Company's unrecognized tax benefits, excluding interest and penalties of $300, as of October 3, 2026, are as follows:
2026
Unrecognized tax benefits at beginning of year$— 
Additions based on tax positions related to the current year61 
Additions for tax positions of prior years5,462 
Net change in unrecognized tax benefits$5,523 
Unrecognized tax benefits at end of year$5,523 
As of September 27, 2025 and September 28, 2024, we had no uncertain tax positions.
We record unrecognized tax benefits as liabilities and we adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Further, we record interest and penalties related to unrecognized tax benefits in income tax expense. We identified, in the current year, additional expenditures qualifying for U.S. research and development tax credits through an enhanced review of our research activities and related costs. As a result, we recorded a discrete income tax benefit offset by a reduction representing unrecognized tax benefits related to the additional qualifying expenditures.
We are subject to income taxes in the U.S. and in various states and foreign jurisdictions. With few exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities in significant jurisdictions for years before 2023.
The Organization for Economic Cooperation and Development issued Pillar Two model rules for a global minimum tax of 15% effective January 1, 2024. Pillar Two had no impact on our fiscal year ended October 3, 2026 and September 27, 2025 effective income tax rate, and we do not expect Pillar Two to significantly impact our effective income tax rate going forward.